Stathis A, Pirosa MC, Orsucci L, Feugier P, et al. IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. Haematologica 2024 Feb 22. doi: 10.3324/haematol.2023.283918.
PMID: 38385243